PFC
MD icon

Poplar Forest Capital’s Pediatrix Medical MD Stock Holding History

Poplar Forest Capital’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5,700
Closed -$344K – 65
2017
Q2 		$344K Hold
5,700
– – 0.03% 62
2017
Q1 		$395K Buy
+5,700
New +$396K 0.03% 51

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Poplar Forest Capital's MD Position: Q3 2017 in Review

Poplar Forest Capital sold out of Pediatrix Medical (MD) in Q3 2017, closing a stake of 5,700 shares — an estimated $344K sold.

Poplar Forest Capital first reported a position in MD in Q1 2017 and held it in 2 quarters. The position peaked at $395K in Q1 2017. 337 funds tracked by Wall St. Rank hold MD as of Q3 2017.

  • Poplar Forest Capital reported no remaining Pediatrix Medical position as of Q3 2017 after selling out during the quarter.
  • Poplar Forest Capital sold 5,700 Pediatrix Medical shares in Q3 2017, an estimated $344K.
  • Poplar Forest Capital first reported a position in Pediatrix Medical in Q1 2017 and held it in 2 quarters.
  • Poplar Forest Capital's Pediatrix Medical position peaked at $395K in Q1 2017.
  • 337 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2017.

Based on Poplar Forest Capital's 13F filing for Q3 2017, filed 13 Nov 2017.